Ovarian Cancer Drug Developments A once-daily pill called Niraparib has been approved in the U.K. after studies found it can add an extra 16 months to an ovarian cancer patient’s life…
Surgical Mesh Devices Abroad Slow Response to Mesh Injuries Worries NZ Health Minister Problems with surgical mesh have arisen across the pond. New Zealand’s Minister of Health, David Clark, met with…
A recent $417 million verdict, awarded to California ovarian cancer patient Eva Echeverria, was considered a victory for the hundreds of women who used Johnson & Johnson’s Baby Powder. Researchers have…
Scientists at the John Hopkins Kimmel Cancer Center (JHKCC) and Dana Farber Cancer Institute have found that ovarian cancer may originate in the fallopian tubes. Tissue samples studied from five women…
Ovarian cancer is the fifth most common cancer in women, as well as the most common cause of gynecologic cancer death. The lack of screening tools means that by the time…